Skip to content

Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02826174
Enrollment
60
Registered
2016-07-07
Start date
2015-12-31
Completion date
2016-12-31
Last updated
2016-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Opacity, Keratitis, Herpetic, Corneal Ulcer, Corneal Dystrophies, Hereditary

Brief summary

Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for more than 100 years. Because conventional PKP is associated with the potential for the development of devastating complications such as expulsive suprachoroidal hemorrhage and endophthalmitis, we modified the technique to one that is a closed surgery under topical anesthesia with the anterior chamber maintained to achieve favorable results. Topical anesthesia is an attractive alternative to traditional injection local anesthesia since the potentially serious complications associated with retrobulbar and peribulbar anesthesia can be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the open nature of conventional PKP. The advantages, i.e., decreased surgical risks, postoperative complications, and surgical difficulties, make PKP viable in most complicated cases.

Interventions

PROCEDUREclosed PKP under topical anesthesia

a closed corneal transplantation under topical anesthesia with the anterior chamber maintained

PROCEDUREopen-sky PKP under retrobulbar anesthesia

an open-sky corneal transplantation under retrobulbar anesthesia

DRUGAnti-Rejection Agents

Anti-Rejection Agents for both groups

Anti-Inflammatory Agents for both groups

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* active bacterial keratitis, for which ulceration progressed despite maximum antibacterial medication; * refractory fungal keratitis that did not respond to antifungal agents; * nonactive HSK, for which corneal opacities with or without new vessels involved the optical zone; * ocular acid burn and thermal burn with partial limbal deficiency (50% or less) that, after more than half a year of preoperative treatment, showed reepithelialization and less than 2 quadrants limbal neovascularization.

Exclusion criteria

* Patients with keratolimbal allograft transplantation, total limbal stem cell deficiency secondary to ocular burns, and other ocular diseases (ie, amblyopia, age-related cataract, glaucoma, macular edema, and mac ular degeneration) were excluded.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuitypreoperative

Secondary

MeasureTime frame
Endothelial cell density1 week after PKP

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026